Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre-Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators
ESC Heart Failure, 15 December 2024 | https://doi.org/10.1002/ehf2.15124
Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles
Borlongan CV, Lee J-Y, D’Egidio F, de Kalbermatten M, Garitaonandia I, Guzman R,
Stem Cells Translational Medicine, Volume 13, Issue 11, November 2024, Pages 1043–1052, https://doi.org/10.1093/stcltm/szae072
Regenerative Medicine for Cardiovascular Disease: Characterization and Clinical Success.
Garitaonandia IBioprocess International April 2024 22(4) Pages 24-29
Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic Stroke.
Lee J-Y, Cho J, D’Egidio F, Vignon C, Streefkerk H, de Kalbermatten M, Garitaonandia I, Borlongan CV
Stem Cells Translational Medicine, Volume 13, Issue 2, February 2024, Pages 177–190, https://doi.org/10.1093/stcltm/szad081
Development of a potency assay for CD34+ cell-based terapy.
Aries A, Vignon C, Zanetti C, Goubaud A, Cormier A, Diederichs A, Lahlil R, Hénon P, Garitaonandia I Sci Rep 13, 19665 (2023). https://doi.org/10.1038/s41598-023-47079-8
Transforming Perspectives in Cardiac Cell Therapy: Hypothesis and Commentary Following Updated Results of a Pilot Study Investigating Very Long-Term Clinical Outcomes in Severe AMI Patients Following Trans-Epicardial Injection of Peripheral Blood CD34+ Cells.
Hénon P, Bischoff N, Dallemand R
Stem Cell Rev and Rep. (2024) 20, 247–257.
Deciphering the Cardiovascular Potential of Human CD34+ Stem Cells.
Aries A, Zanetti C, Hénon P, Drénou B, Lahlil R. Int J Mol Sci. 2023 May 31;24(11):9551. doi: 10.3390/ijms24119551. PMID: 37298503; PMCID: PMC10253329.
Vignon C, Hilpert M, Toupet K, Goubaud A, Noël D, de Kalbermatten M, Hénon P, Jorgensen C, Barbero A, Garitaonandia I. Front Bioeng Biotechnol. 2023 May 23;11:1150522. doi: 10.3389/fbioe.2023.1150522. PMID: 37288358; PMCID: PMC10242004.
Hénon P, Kowalczyk M, Aries A, Vignon C, Trébuchet G, Lahlil R. Stem Cell Rev Rep. 2022 Jun;18(5):1614-1626. doi: 10.1007/s12015-022-10373-5. Epub 2022 Apr 14. PMID: 35420389; PMCID: PMC9209364.
CD34+ Stem Cells and Regenerative Medicine.
Hénon P, Lahlil R, Stem Cells Latest Advances (2021). Springer, pp 21-34, https://doi.org/10.1007/978-3-030-77052-5_2
Key Success Factors for Regenerative Medicine in Acquired Heart Diseases.
Hénon P Stem Cell Rev Rep. 2020 Jun;16(3):441-458. doi: 10.1007/s12015-020-09961-0. PMID: 32297205; PMCID: PMC7253501.
Saucourt C, Vogt S, Merlin A, Valat C, Criquet A, Harmand L, Birebent B, Rouard H, Himmelspach C, Jeandidier É, Chartois-Leauté AG, Derenne S, Koehl L, Salem JE, Hulot JS, Tancredi C, Aries A, Judé S, Martel E, Richard S, Douay L, Hénon P. Stem Cells Transl Med. 2019 Aug;8(8):822-832. doi: 10.1002/sctm.17-0277. Epub 2019 Apr 29. PMID: 31037857; PMCID: PMC6646685.
Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP. Cytotherapy. 2009;11(8):1002-15. doi: 10.3109/14653240903164963. PMID: 19929464.